Q2 2026 Ambu A/S Earnings Call Transcript
/- -
Hello, and good late morning to everyone, and welcome to our Q2 earnings call for Ambu, where we'll go through our business highlights and financial results from the second quarter in our fiscal year. So my name is Britt Meelby Jensen. I'm the CEO of Ambu. And with me today, I have Henrik Skak Bender, our Chief Financial Officer. So let me start with the business highlights from the first six months of our financial year, starting talking about our key growth driver, Endoscopy Solutions where we are leaders in the single-use market and where we are continuing to drive a structural conversion in the market from reducible to single-use.
We delivered in the first half of the year, 14.1% growth. The guidance, which we are on plan with for the year on Endoscopy Solutions is plus 15% revenue growth. We also -- when we set that guidance back in November, we said that we will have a higher growth in the second half of the year than the first half of the year. So with 14.1% for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

